Market Herald logo

Subscribe

Be the first with the news that moves the market
  • IMV Inc (TSX:IMV) has announced that the company will present at the 2020 BIO CEO and Investor Conference next month.
  • Management team members will give the presentation on February 10th, at the Marriott Marquis Hotel in New York.
  • A live webcast and replay of the presentation will be accessible online.
  • IMV’s share price is up 0.33 per cent, with shares trading at $6.16 apiece.

Representatives from biopharmaceutical company IMV Inc (IMV) will give a presentation at the BIO CEO and Investor Conference in February. The two-day conference will take place at the Marriott Marquis Hotel in New York City.

The occasion will bring together investors, industry analysts, and senior executives from biotechnology companies. The event is a great opportunity to let investors know about the novel class of immunotherapies which IMV is currently pioneering.

The conference will take place on February 10th and 11th, with company presentations on both days. IMV’s presentation is scheduled for Monday February 10th, at 9:30am Eastern Standard Time.

A live webcast of the presentation will be made available on the investors section of IMV’s website, under Events, Webcasts, and Presentations.

A replay will also be accessible, roughly one hour after the presentation. It will continue to be available for approximately 30 days.

IMV’s share price is up 0.33 per cent, with shares trading at $6.16 apiece.

More From The Market Herald

" Algernon Pharmaceuticals (CSE:AGN) discloses novel salt patent strategy

Algernon Pharmaceuticals (AGN) has included novel salt forms of DMT in its intellectual property patent applications for AP-188 (“N,N-dimethyltryptamine” or “DMT”).

" LevelJump Healthcare (TSXV:JUMP) announces $2.5M private placement

LevelJump Healthcare (JUMP) will be conducting a non-brokered private placement financing for gross proceeds of up to $2,500,000.

" Leveljump Healthcare (TSXV:JUMP) provides corporate update

Leveljump Healthcare (JUMP) has agreed to acquire an additional minority interest in Real Time Medical (RTM), Shaw Lens, and Shaw Vision.

" PharmaDrug (CSE:PHRX) engages Octagon Media for an investor marketing campaign

PharmaDrug Inc. (PHRX) has engaged Octagon Media Corp to assist in a digital media advertising campaign coupled with an investor marketing program.